Sign in
4/A

Changes in Ownership

GALECTIN THERAPEUTICS INC Filed Acc 0001493152-25-026587

10% owner sold 162,069 shares at an average $5.68 ($920,855)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
10X Fund, L.P. 10% owner 2025-12-02 Sale −30,000 $5.47 $164,100 5,802,207 D: show line 1 in the form
10X Fund, L.P. 10% owner 2025-12-03 Sale −132,069 $5.73 $756,755 5,670,138 D: show line 2 in the form
Open-market sales · 162,069 sh · avg $5.68 · $920,855
Loading xslF345X05/ownership.xml…